Hongcheng Luo

534 total citations
25 papers, 377 citations indexed

About

Hongcheng Luo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Hongcheng Luo has authored 25 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Hongcheng Luo's work include MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Hongcheng Luo is often cited by papers focused on MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (7 papers). Hongcheng Luo collaborates with scholars based in China. Hongcheng Luo's co-authors include Qisheng Luo, Huatuo Huang, Chunfang Wang, Yan Lan, Tingzhuang Yi, Zhongquan Qi, Ye‐Sheng Wei, Chuandong Wei, Xiaopeng Luo and Yu Liu and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Brain Research.

In The Last Decade

Hongcheng Luo

25 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongcheng Luo China 12 247 173 65 46 32 25 377
Huatuo Huang China 13 147 0.6× 108 0.6× 84 1.3× 51 1.1× 43 1.3× 27 322
Jingchao Zhou China 7 264 1.1× 171 1.0× 34 0.5× 35 0.8× 9 0.3× 7 354
Nicole Jackson Australia 8 131 0.5× 161 0.9× 114 1.8× 54 1.2× 29 0.9× 9 405
Natalia Baulina Russia 14 271 1.1× 204 1.2× 113 1.7× 21 0.5× 34 1.1× 42 474
Erna A Peters Netherlands 11 274 1.1× 123 0.7× 109 1.7× 37 0.8× 13 0.4× 14 438
Jian Fan China 10 343 1.4× 112 0.6× 43 0.7× 20 0.4× 18 0.6× 26 475
Hendrika A. B. Peters Netherlands 13 246 1.0× 119 0.7× 151 2.3× 41 0.9× 27 0.8× 27 502
Stephanie Lapping United States 6 183 0.7× 60 0.3× 75 1.2× 17 0.4× 15 0.5× 10 311
Heiko Roedig Germany 8 215 0.9× 57 0.3× 105 1.6× 82 1.8× 12 0.4× 8 391
Aierpati Maimaiti China 10 121 0.5× 85 0.5× 25 0.4× 28 0.6× 14 0.4× 30 265

Countries citing papers authored by Hongcheng Luo

Since Specialization
Citations

This map shows the geographic impact of Hongcheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongcheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongcheng Luo more than expected).

Fields of papers citing papers by Hongcheng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongcheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongcheng Luo. The network helps show where Hongcheng Luo may publish in the future.

Co-authorship network of co-authors of Hongcheng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Hongcheng Luo. A scholar is included among the top collaborators of Hongcheng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongcheng Luo. Hongcheng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Hongcheng, et al.. (2024). Upregulation of miR-499a Targets Beclin1 to Modulate Astrocyte Autophagy and Promote Ischemic Stroke.. PubMed. 54(1). 47–55. 2 indexed citations
2.
Luo, Qisheng, Junhong Zhuang, Dandan Zheng, et al.. (2023). IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. Frontiers in Immunology. 14. 1282734–1282734. 5 indexed citations
3.
Luo, Hongcheng, et al.. (2022). miR-150-3p enhances neuroprotective effects of neural stem cell exosomes after hypoxic-ischemic brain injury by targeting CASP2. Neuroscience Letters. 779. 136635–136635. 42 indexed citations
5.
Lu, Yulan, Huatuo Huang, Chunfang Wang, et al.. (2021). Association of LncRNA‐GAS5 gene polymorphisms and PBMC LncRNA‐GAS5 level with risk of systemic lupus erythematosus in Chinese population. Journal of Cellular and Molecular Medicine. 25(7). 3548–3559. 16 indexed citations
6.
7.
Liu, Yang, Wei Xiao, Hongcheng Luo, et al.. (2021). CCT5 interacts with cyclin D1 promoting lung adenocarcinoma cell migration and invasion. Biochemical and Biophysical Research Communications. 567. 222–229. 19 indexed citations
8.
Chen, Zigui, Yingying Xie, Hongcheng Luo, et al.. (2021). NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun. Aging. 13(24). 26180–26200. 23 indexed citations
9.
Luo, Hongcheng, et al.. (2020). Role of long noncoding RNA MEG3/miR-378/GRB2 axis in neuronal autophagy and neurological functional impairment in ischemic stroke. Journal of Biological Chemistry. 295(41). 14125–14139. 42 indexed citations
10.
Luo, Qisheng, Tianshi Que, Hongcheng Luo, et al.. (2020). Upregulation of DEAD box helicase 5 and 17 are correlated with the progression and poor prognosis in gliomas. Pathology - Research and Practice. 216(3). 152828–152828. 9 indexed citations
11.
Yi, Tingzhuang, et al.. (2020). LncRNA LL22NC03-N14H11.1 promoted hepatocellular carcinoma progression through activating MAPK pathway to induce mitochondrial fission. Cell Death and Disease. 11(10). 832–832. 30 indexed citations
12.
Wei, Guijiang, Mingqing Yuan, Lihe Jiang, et al.. (2019). A Genetic Variant of miR-34a Contributes to Susceptibility of Ischemic Stroke Among Chinese Population. Frontiers in Physiology. 10. 432–432. 11 indexed citations
13.
14.
Lu, Yulan, Rong Wang, Huatuo Huang, et al.. (2018). Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population. Scientific Reports. 8(1). 971–971. 18 indexed citations
15.
Huang, Huatuo, Jing Guo, Yang Xiang, et al.. (2017). A SNP in 5′ untranslated region of CD40 gene is associated with an increased risk of ischemic stroke in a Chinese population: a case-control study. Genetics and Molecular Biology. 40(2). 442–449. 3 indexed citations
16.
Luo, Hongcheng, et al.. (2017). Association of miR-146a, miR-149, miR-196a2, miR-499 gene polymorphisms with ischemic stroke in a Chinese people. Oncotarget. 8(46). 81295–81304. 21 indexed citations
17.
Chen, Jianming, et al.. (2016). [Association of SNP of leukocyte differentiation antigen-CD40 gene and its serum level with ischemic stroke].. PubMed. 50(3). 239–43. 2 indexed citations
18.
Guo, Jinghui, Hongcheng Luo, Chuandong Wei, et al.. (2015). Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus. Rheumatology International. 36(1). 45–52. 21 indexed citations
19.
Chen, Jianming, Jing Guo, Chuandong Wei, et al.. (2015). The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus. BMC Genetics. 16(1). 121–121. 37 indexed citations
20.
Song, Luyao, et al.. (2014). [Effect of Smilax china bioactive fraction on tumor necrosis factor-α and interleukin-4 contents in uterine tissue of rats with chronic pelvic inflammatory disease].. PubMed. 34(2). 236–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026